Apathy in older age: why it might signal neurodegeneration
-
By
-
Masud Husain
-
December 4, 2025
-
Clinical Scorecard: Apathy in the Elderly: Potential Indicator of Neurodegenerative Disorders
At a Glance
| Category | Detail |
|---|
| Condition | Apathy in older adults |
| Key Mechanisms | Reduced motivation and initiation of activities; associated with Alzheimer’s disease pathology and mild behavioural impairment |
| Target Population | Older adults, particularly those in their seventies and above |
| Care Setting | Community and memory clinics |
Key Highlights
- Approximately 20% of individuals in their seventies exhibit apathy, which can lead to disengagement from daily activities and social interactions.
- Apathy in older adults is linked to a greater than 2.5-fold increased risk of developing dementia, including Alzheimer’s disease.
- Mild behavioural impairment (MBI), including apathy and other neuropsychiatric symptoms, may be an early manifestation of neurodegenerative disease.
Guideline-Based Recommendations
Diagnosis
- Screen for apathy and other neuropsychiatric symptoms as part of dementia risk assessment.
- Obtain history from informants or use questionnaires to assess apathy due to possible lack of patient insight.
- Differentiate apathy from depression as they are distinct syndromes but may co-occur.
Management
- Currently, no licensed therapies exist for apathy; treatment strategies are under investigation.
- Clinicians should be aware of the impact of apathy on quality of life and monitor accordingly.
Monitoring & Follow-up
- Regular evaluation of behavioural changes alongside cognitive assessments in older adults.
- Monitor for progression of apathy and emergence of other neuropsychiatric symptoms indicative of neurodegeneration.
Risks
- Apathy is associated with increased risk of dementia and may indicate underlying Alzheimer’s disease pathology.
- Failure to recognize apathy may delay identification of neurodegenerative disorders.
Patient & Prescribing Data
Older adults with apathy, including those with mild cognitive impairment or normal cognition
No licensed treatments currently; research ongoing into potential therapeutic strategies.
Clinical Best Practices
- Incorporate apathy screening into routine assessments for older adults at risk of dementia.
- Use informant reports or validated questionnaires to improve detection of apathy.
- Recognize apathy as a distinct clinical syndrome separate from depression.
- Educate patients and caregivers about the significance of apathy as a possible early sign of neurodegeneration.
References
